PM.20.031 – Towards better classification and treatment of lobular breast cancer: the European Lobular Breast Cancer Consortium (ELBCC).
Route: Personalised medicine: the individual at the centre
cluster question: 085 Every tumour is different, so how can we come to understand cancer well enough to develop a treatment for each and every type?
BackgroundTo personalize treatment of breast cancer patients, different classification systems have been developed for which the morphological classification is still […]
View the initiative
PM.20.032 – Improving diagnostics and prognostics in disorders of consciousness: An integrative approach
Route: Personalised medicine: the individual at the centre
cluster question: 104 How do we develop minimally invasive techniques and interventions for diagnosis, prognosis, and treatment?
Due to improvements in emergency treatment and life support, more people survive life-threatening incidents such as a cardiac arrest and […]
View the initiative
PM.20.033 – Personalized medicine: the individual in focus
Route: Personalised medicine: the individual at the centre
cluster question: 076 What are the consequences of chronic disorders, stress, and disabilities and what is the best way to deal with them?
Sickle cell disease and thalassemia are among the most common hereditary diseases in the world. Both diseases result in chronic […]
View the initiative
PM.20.034 – Exploring the beta cell ligandome for type 1 diabetes diagnostic
Route: Personalised medicine: the individual at the centre
cluster question: 087 What causes type 1 and type 2 diabetes, how can we detect them sooner, and how can we treat them on an individual basis?
Diabetes currently affects 425 million people, with an estimated worldwide prevalence of 8%, and a further projected increase to 642 […]
View the initiative
PM.20.020 – Defining the immunological landscape to develop personalized medicine strategies across disease & age
Route: Personalised medicine: the individual at the centre
cluster question: 095 How can we personalise health care, for example by using biomarkers?
The striking patient-to-patient heterogeneity of chronic immune-mediated inflammatory disorders (IMIDs) such as Crohn’s disease, ulcerative colitis, rheumatoid arthritis, and atopic […]
View the initiative
PM.20.021 – Transitioning to a personalised breast cancer screening and prevention paradigm: delivering the final pieces of the implementation puzzle
Route: Personalised medicine: the individual at the centre
cluster question: 095 How can we personalise health care, for example by using biomarkers?
Implementation of risk stratification, biomarkers, and artificial intelligence in breast cancer screening is already at the forefront of politicians’ and […]
View the initiative
PM.20.023 – Proton therapy: less is more
Route: Personalised medicine: the individual at the centre
cluster question: 094 How do we improve the quality of health care as much as possible while keeping it affordable?
Cancer radiation therapy is often associated with severe damage of surrounding healthy tissue and can even result in death. Proton […]
View the initiative
PM.20.024 – Sphingolipids in life and disease: in science, clinic and society
Route: Personalised medicine: the individual at the centre
cluster question: 083 How do neurological, psychiatric, and mental disorders arise, and how can we prevent, mitigate, or cure them?
Lipids are essential for life and abnormalities in their production and/or breakdown may reflect ongoing diseases such as in the […]
View the initiative
PM.20.025 – Personalized treatment for mental disorders: using routine data for shared decision making and precision medicine
Route: Personalised medicine: the individual at the centre
cluster question: 095 How can we personalise health care, for example by using biomarkers?
Mental disorders are highly prevalent and create an enormous societal and personal burden. However, current treatments mostly have limited effects. […]
View the initiative
PM.20.019 – Novel biomarkers to predict individual arm-hand recovery and improve functional outcome after stroke
Route: Personalised medicine: the individual at the centre
cluster question: 095 How can we personalise health care, for example by using biomarkers?
Post-stroke recovery of upper-limb capacity is crucial for independence and quality of life. Due to improved acute care, the number […]
View the initiative